Assay Detail
Binding
CHEMBL4723161
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of SARS-CoV 3C-like protease expressed in Escherichia coli BL21 (DE3) using ABCYL-KTSAVLQSGFRKME-EDANS as substrate preincubated for 1 hr followed by substrate addition and measured after 16 hrs by FRET assay
3
Total Activities
3
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Severe acute respiratory syndrome-related coronavirus |
| Confidence | 0 — Uncurated / Unknown |
| Curated By | Autocuration |
Publication
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 3 | 4.49 | 4.56 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL395990 | RHOIFOLIN | — | 1 | 4.56 |
| CHEMBL611029 | HERBACETIN | — | 1 | 4.48 |
| CHEMBL445978 | PECTOLINARIN | — | 1 | 4.42 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL395990 | RHOIFOLIN | IC50 | = | 27400.0 | nM | 4.56 |
| CHEMBL611029 | HERBACETIN | IC50 | = | 33100.0 | nM | 4.48 |
| CHEMBL445978 | PECTOLINARIN | IC50 | = | 37700.0 | nM | 4.42 |